EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Identification of a Founder GLDN Variant Associated With “Lethal” Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long‐Term Survivors' Management

Alexa McAdam, Yoko A Ito, Marilyn Richard, Dan Spiegelman, Daniel Rochefort, Lan Xiong iD, Maryam Oskoui, David Zielinski, Guy A Rouleau iD, Sirui Zhou, Care4Rare Canada Consortium, Kym M Boykott iD und 1 weitere

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.63974 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Alexa McAdam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada. Hauptthemen laut MEDLINE: Inuit, Arthrogryposis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Ontario Genomics Institute, Genome Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biallelic variants in GLDN have recently been associated with lethal congenital contracture syndrome 11 (LCCS11), a form of fetal akinesia deformation sequence (FADS) with high neonatal mortality. In this report, we describe five individuals from two Canadian Inuit families originating from different communities in Nunavik all affected with FADS and harboring a rare homozygous missense variant, [NM_181789.4:c.82G >C p.(Ala28Pro)] in GLDN . Two pregnancies presented with significant obstetrical complications including placental abruption and hemorrhage. Four infants died shortly after birth, while one survived past the neonatal period. This individual, while apparently asymptomatic during infancy, then presented with progressive neuromuscular and respiratory compromise that became more evident in adolescence. Data from a Nunavik Inuit cohort demonstrated a minor allele frequency (MAF) of 0.03571 for this variant compared to 0.00001341 in the general population, suggesting a founder effect in the Nunavik Inuit population. Our findings support the presence of a founder variant associated with LCCS11 in Nunavik Inuit populations. Our data corroborate those of other reports, demonstrating that LCCS11 is not universally lethal, but long‐term survivors are at risk of progressive neuromuscular compromise. We also highlight in this report the significant obstetrical complications associated with this fetal‐onset condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InuitArthrogryposisHumansFemalePregnancyFounder EffectSurvivorsInfant, NewbornMalePedigreeCanadaInfantGene FrequencyMutation, MissenseAdolescentAdultHomozygote

Stichwörter der Autor:innen

GLDNFADSInuitLCCS11Nunavikfetal akinesia deformation sequencefounder variantgliomedinlethal congenital contractures syndrome

Autor:innen und Institutionen

  • Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
  • Division of Genome Diagnostics, BC Children's and BC Women's Hospital, Vancouver, British Columbia, Canada.
  • Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
  • Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
  • Centre Hospitalier Universitaire mère-Enfant Sainte-Justine, Université de Montréal, Montréal, Quebec, Canada.
  • Montreal Neurological Institute-Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

ORCID-Profile: Lan Xiong, Guy A Rouleau, Kym M Boykott, Isabelle De Bie

Förderung

  • CIHR
  • Ontario Genomics Institute
  • Genome Canada
  • Génome Québec
  • Genome British Columbia
  • Genome Alberta
  • Ontario Research Fund
  • Canada Research Chair in Rare Disease Precision Health

Zitieren

APA

McAdam, A., Ito, Y. A., Richard, M., Spiegelman, D., Rochefort, D., Xiong, L., Oskoui, M., Zielinski, D., Rouleau, G. A., Zhou, S., Care4Rare Canada Consortium, Boykott, K. M., & De Bie, I. (2025). Identification of a Founder GLDN Variant Associated With “Lethal” Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long‐Term Survivors' Management. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63974

Vancouver

McAdam A, Ito YA, Richard M, Spiegelman D, Rochefort D, Xiong L, et al. Identification of a Founder GLDN Variant Associated With “Lethal” Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long‐Term Survivors' Management. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63974

BibTeX
@article{McAdam2025,
  author = {McAdam, Alexa and Ito, Yoko A and Richard, Marilyn and Spiegelman, Dan and Rochefort, Daniel and Xiong, Lan and Oskoui, Maryam and Zielinski, David and Rouleau, Guy A and Zhou, Sirui and Care4Rare Canada Consortium, Care4Rare Canada Consortium and Boykott, Kym M and De Bie, Isabelle},
  title = {Identification of a Founder GLDN Variant Associated With “Lethal” Arthrogryposis in Nunavik Inuit: Implications for Obstetrical and Long‐Term Survivors' Management},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.63974}
}
Kostenlos starten →